CRISPR THERAPEUTICS AG
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for CRISPR THERAPEUTICS AG NAMEN AKT, CUSIP H17182958.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for CRISPR THERAPEUTICS AG NAMEN AKT, CUSIP H17182958.